# EDGAR Filing Document

**Accession Number:** 0000773141
**File Stem:** 0001062993-23-002251
**Filing Date:** 2023-2
**Character Count:** 10283
**Document Hash:** 6278d52cea15f663b0ac811d744d99bc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-002251.hdr.sgml**: 20230206

**ACCESSION NUMBER**: 0001062993-23-002251

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230203

**FILED AS OF DATE**: 20230206

**DATE AS OF CHANGE**: 20230206

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Martin Robert Nathaniel
- **CENTRAL INDEX KEY:** 0001643076

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08951
- **FILM NUMBER:** 23590509

**MAIL ADDRESS:**
- **STREET 1:** 4350 S. MONACO STREET
- **STREET 2:** SUITE 500
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80237
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** M.D.C. HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0000773141
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPERATIVE BUILDERS [1531]
- **IRS NUMBER:** 840622967
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4350 S MONACO STREET
- **STREET 2:** SUITE 500
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80237
- **BUSINESS PHONE:** 3037731100

**MAIL ADDRESS:**
- **STREET 1:** 4350 S MONACO STREET
- **STREET 2:** SUITE 500
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80237

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MDC HOLDINGS INC
- **DATE OF NAME CHANGE:** 19920703

## Exhibit 24.1

```

POWER OF ATTORNEY

      Regarding M.D.C. Holdings, Inc. (Company), the undersigned
hereby constitutes and appoints each of Michael l. Kaplan and
Joseph H. Fretz, signing singly, and with full power of
substitution, the undersigned?s true and lawful attorney-in-fact
to:

1.	execute for and on behalf of the undersigned any and all
reports (including amendments) under Section 16 of the
Securities Exchange Act of 1934, including Forms 3, 4 and
5, as such law (and related rules) and forms, may be
amended from time to time;

2.	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
the execution of any such reports (including Form 3, 4 and
5 and any amendments thereto), and the timely filing of
such reports and forms with the United States Securities
and Exchange Commission, the New York Stock Exchange, and
any other authority where such reports and forms are
required to be filed; and

3.	take any other action of any type whatsoever in connection
with the foregoing which, in the judgment of such attorney-
in-fact, may be of benefit to, in the best interest of, or
legally required by the undersigned, it being understood
that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may approve in such
attorney-in-fact?s discretion.

      The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform all and every act and
thing whatsoever requisite, necessary and proper to be done in
the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as such attorney-in-fact might
or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or his/her substitute or
substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted.

      The undersigned acknowledges that the foregoing attorneys-
in-fact, in serving in such capacity at the request of the
undersigned, are not assuming any of the undersigned's
responsibilities to comply with or liabilities under Section 16
of the Securities Exchange Act of 1934.  This Power of Attorney
does not relieve the undersigned from responsibility for
compliance with the undersigned's obligations, including
reporting requirements, under Section 16 of the Exchange Act.

      This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file
reports under Section 16 (including Forms 3, 4 and 5) with
respect to the undersigned?s holdings of and transactions in
securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.  This Power of Attorney revokes all previous
powers of attorney with respect to the subject matter of this
Power of Attorney.

      Accordingly, the undersigned has executed this Power of
Attorney, effective as of October 26, 2022.

/s/ Robert N. Martin
Signature

	Page 1 of 2

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Martin Robert Nathaniel<br><sub>(Last) (First) (Middle)</sub><br>4350 S. MONACO ST.<br>SUITE 500<br><sub>(Street)</sub><br>DENVER, CO 80237<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-03 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_SVP and CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>M.D.C. HOLDINGS, INC. [ MDC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock $.01 Par Value | 2023-02-03 |  | F |  | 1356<sup>(1)</sup> | D | 40.33<sup>(2)</sup> | 218251 | D |  |
| Common Stock $.01 Par Value | 2023-02-03 |  | F |  | 6248<sup>(1)</sup> | D | 40.33<sup>(2)</sup> | 212003 | D |  |
| Common Stock $.01 Par Value | 2023-02-03 |  | A |  | 49590<sup>(3)</sup> | A | $0 | 261593 | D |  |
| Common Stock $.01 Par Value | 2023-02-03 |  | A |  | 64800<sup>(4)</sup> | A | $0 | 326393 | D |  |
| Common Stock $.01 Par Value | 2023-02-03 |  | F |  | 25034<sup>(5)</sup> | D | 40.33<sup>(2)</sup> | 301359 | D |  |
| Common Stock $.01 Par Value | 2023-02-04 |  | F |  | 1397<sup>(1)</sup> | D | 40.33<sup>(2)</sup> | 299962 | D |  |
| Common Stock $.01 Par Value |  |  |  |  |  |  |  | 511 | I | By 401(k)<sup>(6)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Restricted stock vesting -- share withholding pursuant to irrevocable election made outside of blackout periods.

(2) Closing Price on February 3, 2023

(3) Shares of restricted stock granted on February 3, 2023 for no cash consideration pursuant to the Company's 2021 Equity Incentive Plan and a Restricted Stock Agreement.  The restrictions will lapse as to 33-1/3% of the shares over three years starting with the first anniversary of the grant date.

(4) Vesting of Performance Share Unit (PSU) award originally granted on August 20, 2020.

(5) PSU vesting - share withholding pursuant to irrevocable election made outside blackout periods.

(6) Unitized shares held in a stock fund in the Reporting Person's 401(k) Savings Plan which changes on a daily basis.

**Signature:** Robert N. Martin  
**Date:** 2023-02-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**